Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
+1.25 (14.29%)
Jul 28, 2025, 4:26 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 9.94 million as of July 28, 2025. Its market cap has increased by 259.59% in one year.
Market Cap
9.94M
Enterprise Value
9.54M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 9.94M, a decrease of -63.55%. That is a compound annual growth rate of -12.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 9.94M | 47.01% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | 31.54M | 81.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| GSK plc | 56.21B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.21B |
| Oxford Nanopore Technologies | 2.02B |